Akili Labs Seeks To Provide Diagnostics Products That Make Healthcare Accessible
Akili Labs Seeks To Provide Diagnostics Products That Make Healthcare Accessible. Akili Labs is an award-winning biotechnology company specializing in molecular diagnostic systems development, it was founded by Charles Faul and Lucas Lotter in 2017, with Dr Farhan Pervaiz joining as a co-founder in 2018.
Based in South Africa with international affiliates, Akili Labs was established after realizing the need for easy access to fast-paced diagnostics in the healthcare system. With innovation and collaboration at the forefront of its company purpose, Akili Labs constantly forges partnerships with organizations around the globe for the development, creation and implementation of healthcare and diagnostic-related products. The company develops affordable, reliable and state of the art diagnostics. It also innovates products for the right environment to make healthcare more accessible.
Akili Labs is an innovative biotechnology company pioneering molecular diagnostics to advance the global healthcare system. Partnering is part of its process as it believes that through working together on research, product development & implementation, they can engineer products that are more reliable and more versatile to ultimately revolutionise the global healthcare system. Frontline medical staff is faced with various challenges at the point-of-care level without having the necessary infrastructure at their disposal. The development of a mobile molecular diagnostic device, the Akili MDx, assists healthcare professionals with accurate diagnostics in the lab and in-field. The Akili MDx is in development and will assist in quick & early pathogen detection at a genetic level of HIV, Influenza, SARS-CoV-2 and future novel viruses.
The company is proud to have joined forces with a broad spectrum of leaders in diagnostics, business and healthcare & innovation technology. Akili Labs has worked closely with Phithos in the establishment of a pathology laboratory with an initial focus on Covid-19 testing. Akili Labs has also collaborated with New England Biolabs. The company is working on creating hardware that can leverage the fantastic potential of their LAMP chemistry. The Technology Partnership (TTP) and their world-class expertise assist in the development of Akili Labs diagnostic devices and introducing it to market. With the help of Founders Factory Africa and Netcare, it has gained access to markets in Africa and around the world with joint efforts in business development & fundraising.
The company managed to become the winner of the GAP BioSciences Competition 2017, secured a TIA grant from the Savant Technology incubator 2017 and has represented South Africa at Collision 2018 in New Orleans.
